bpc-157 human clinical trials 2025 2026 BPC-157: Top Peptide for Injury Recovery & Gut Health Support International Clinical Trials Day 2026:

Each capsule contains 50 mg of 5-Amino-1MQ , with 60 capsules per bottle , providing a standardized format suitable for controlled investigational and analytical research environments

The evidence is clear

Storage: Keep refrigerated at 3646F (28C)

Ideal for laboratory preparation, peptide reconstitution, and maintaining sterile research protocols

Contraindications and Precautions Do NOT use AOD-9604 if you: Are pregnant, trying to conceive, or breastfeeding (no safety data in pregnancy/lactation) Have active cancer or history of malignancy (peptide effects on existing cancer unknown) Are under 18 years of age (pediatric safety not established) Have known hypersensitivity to peptides or benzyl alcohol (in bacteriostatic water) Have severe kidney or liver disease without physician clearance Use with caution and enhanced monitoring if you have: Diabetes or glucose metabolism disorders (monitor blood sugar closely despite no expected impact) Cardiovascular disease (comprehensive cardiac evaluation recommended) Thyroid disorders (monitor thyroid function during therapy) History of migraines (may increase headache frequency in susceptible individuals) Drug Interactions Limited formal drug interaction studies exist for AOD-9604

So we've never made it because we're a compounding pharmacy that has to follow the laws of the land because the state and the federal government inspect us